Role of apoptosis signal-regulating kinase-1-c-Jun NH2-terminal kinase-p38 signaling in voltage-gated K+ channel remodeling of the failing heart: Regulation by thioredoxin

Antioxidants and Redox Signaling

Volumn 14, Issue 1, 2011, Pages 25-35

  Tang, Kang ^a   Li, Xun ^b   Zheng, Ming Qi ^a,c   Rozanski, George J ^a,d  

^a NEBRASKA MEDICAL CENTER   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; AURANOFIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OXIDOREDUCTASE; SOMATOMEDIN C; THIOREDOXIN; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHYSIOLOGY; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; VOLTAGE CLAMP;

ANIMALS; HEART FAILURE; HEART VENTRICLES; MALE; MAP KINASE KINASE KINASE 5; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THIOREDOXINS; VENTRICULAR REMODELING;

RATTUS;

EID: 78649456531     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3095     Document Type: Article

References (46)

1. 2-terminal kinase mediates survival of isolated human islets. Endocrinology 145: 4522-4531, 2004.
2. Armoundas AA, Wu R, Juang G, Marban E, and Tomaselli GF. Electrical and structural remodeling of the failing ventricle. Pharmacol Ther 92: 213-230, 2001.
3. Dimitriadis G, Parry-Billings M, Dunger D, Bevan S, Colquhoun A, Taylor A, Calder P, Krause U, Wegener G, and Newsholme EA. Effects of in-vivo administration of insulin-like growth factor-1 on the rate of glucose utilization in the soleus muscle of the rat. J Endocrinol 133: 37-43, 1992.
4. Fedorov VV, Lozinsky IT, Sosunov EA, Anyukhovsky EP, Rosen MR, Balke CW, and Efimov IR. Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 4: 619-626, 2007.
5. Fernandes AP and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.
6. Finn SG, Dickens M, and Fuller SJ. C-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes. Biochem J 358: 489-495, 2001.
7. Galvan V, Logvinova A, Sperandio S, Ichijo H, and Bredesen DE. Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278: 13325-13332, 2003.
8. to1 in shaping action potential morphology and duration. Circ Res 87: 1026-1033, 2000.
9. Hausenloy DJ and Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70: 240-253, 2006.
10. He H, Li HL, Lin A, and Gottlieb RA. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia. Cell Death Differ 6: 987-991, 1999.
11. Honsho S, Nishikawa S, Amano K, Zen K, Adachi Y, Kishita E, Matsui A, Katsume A, Yamaguchi S, Nishikawa K, Isoda K, Riches DWH, Matoba S, Okigaki M, and Matsubara H. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy after affecting Akt and JNK pathways. Circ Res 105: 1149-1158, 2009.
12. Hori M and Nishida K. Oxidative stress and left ventricular remodeling after myocardial infarction. Cardiovasc Res 81: 457-464, 2009.
13. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, and Iwao H. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res 93: 874-883, 2003.
14. Kääb S, Dixon J, Duc J, Ashen D, Nabauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, and Tomaselli GF. Molecular basis of transient outward potassium current downregulation in human heart failure. A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98: 1383-1393, 1998.
15. I in rat ventricular myocytes following myocardial infarction. J Physiol 517(Pt 1): 229-245, 1999.
16. Kashiwase K, Higuchi Y, Hirotani S, Yamaguchi O, Hikoso S, Takeda T, Watanabe T, Taniike M, Nakai A, Tsujimoto I, Matsumura Y, Ueno H, Nishida K, Hori M, and Otsu K. CaMKII activates ASK1 and NF-kB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun 327: 136-142, 2005.
17. Kim A, Khursigara G, Sun X, Franke TF, and Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901, 2001.
18. Krause D, Lyons A, Fennelly C, and O'Connor R. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor 1 receptor can be suppressed by dicumarol. J Biol Chem 276: 19244-19252, 2001.
19. Li WG, Coppey L, Weiss RM, and Oskarsson HJ. Anti-oxidant therapy attenuates JNK activation and apoptosis in the remote noninfarcted myocardium after large myocar-dial infarction. Biochem Biophys Res Commun 280: 353-357, 2001.
20. \+ channel remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288: H1417-H1424, 2005.
21. \+ channel remodeling in rat ventricle. J Mol Cell Cardiol 40: 339-349, 2006.
22. Li X, Tang K, Xie B, Li S, and Rozanski GJ. Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system. Am J Physiol Heart Circ Physiol 295: H416-H424, 2008.
23. Liang H, Li X, Li S, Zheng MQ, and Rozanski GJ. Oxidor-eductase regulation of Kv currents in rat ventricle. J Mol Cell Cardiol 44: 1062-1071, 2008.
24. Liu Q, Sargent MA, York AJ, and Molkentin JD. ASK1 regulates cardiomyocyte death but not hypertrophy in trans-genic mice. Circ Res 105: 1110-1117, 2009.
25. Liu Y and Min W. Thioredoxin promotes ASK1 ubiquitina-tion and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90: 1259-1266, 2002.
26. Mukherjee S, Lekli I, Das M, Azzi A, and Das DK. Cardio-protection with a-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 1728: 498-503, 2008.
27. Murray AJ, Lygate CA, Cole MA, Carr CA, Radda GK, Neubauer S, and Clarke K. Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infracted rat heart. Cardiovasc Res 71: 149-157, 2006.
28. Nadeau PJ, Charette SJ, and Landry J. Redox reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis. Mol Biol Cell 20: 3628-3637, 2009.
29. Nishida K and Otsu K. The role of apoptosis signal-regulating kinase 1 in cardiomyocyte apoptosis. Antioxid Redox Signal 8: 1729-1736, 2006.
30. Nordberg J and Arner ES. Reactive oxygen species, antiox-idants, and the mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312, 2001.
31. Perdiguero E, Ruiz-Bonilla V, Serrano AL, and Muñoz-Cá-noves P. Genetic deficiency of p38a reveals its critical role in myoblast cell cycle exit. The p38a-JNK connection. Cell Cycle 6: 1298-1303, 2007.
32. Posner BJ, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS, and Shaver A. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 296: 4596-4604, 1994.
33. \+ channel remodeling in postinfarction rat heart. Am J Physiol Heart Circ Physiol 282: H2346-H2355, 2002.
34. Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, and Marber MS. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J 14: 2237-2246, 2000.
35. Seddon M, Looi YH, and Shah AM. Oxidative stress and redox signaling in cardiac hypertrophy and heart failure. Heart 93: 903-907, 2007.
36. Singleton JR and Feldman EL. Insulin-like growth factor-1 in muscle metabolism and myotherapies. Neurobiol Dis 8: 541-554, 2001.
37. Smith AD and Levander OA. High-throughput 96-well mi-croplate assay for determining specific activities of gluta-thione reductase and thioredoxin reductase. Methods Enzymol 347: 113-121, 2002.
38. Song JJ and Lee YJ. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase1. Biochem J 373: 845-853, 2003.
39. Teos LY, Zhao A, Alvin Z, Laurence GG, Li C, and Hadda GE. Basal and IGF-1-dependent regulation of potassium channels by MAP kinases and PI3-kinase during eccentric hypertrophy. Am J Physiol Heart Circ Physiol 295: H1834-H1845, 2008.
40. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Monowa O, Miyazono K, Noda T, and Ichijo H. ASK1 is required for sustained activations of JNK=p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228, 2001.
41. 2\+-dependent redox switch in the intracellular T1-T1 interface of a Kv channel. J Biol Chem 282: 13637-13647, 2007.
42. Wang WZ, Gao L, Wang HJ, Zucker IH, and Wang W. Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure. Am J Physiol Heart Circ Physiol 295: H1216-H1226, 2008.
43. Whitmarsh AJ. The JIP family of MAPK scaffold proteins. Biochem Soc Trans 34: 828-832, 2001.
44. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, and Imamura H. IGF-1 differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 280: H1191-H1200, 2001.
45. Zhang H, Tao L, Jiao X, Gao E, Lopez BL, Christopher TA, Koch W, and Ma XL. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia=reperfusion injury in the aging heart. Free Radic Biol Med 43: 39-47, 2007.
46. \+ channel remodeling in postmyocardial infarction rat hearts., Am J Physiol Cell Physiol, 297, C253-C262, 2009.